Evidence map›Paper›PMID 26272050›Full record

Trial reportNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2016

Oxytocin Facilitates Pavlovian Fear Learning in Males.

Monika Eckstein, Dirk Scheele, Alexandra Patin, Katrin Preckel, Benjamin Becker, Annika Walter, Katharina Domschke, Valery Grinevich, Wolfgang Maier, René Hurlemann

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
11.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 87 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Kinetics of oxytocin effects on amygdala and striatal reactivity vary between women and men.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. How does oxytocin modulate human behavior?Molecular psychiatry · 2025
    Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Roles of Oxytocin in Stress Responses, Allostasis and Resilience.International journal of molecular sciences · 2021
    Review
  19. Oxytocin and the Neurobiology of Prosocial Behavior.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Monika EcksteinDepartment of Psychiatry, University of Bonn, Bonn, Germany.
Dirk ScheeleDepartment of Psychiatry, University of Bonn, Bonn, Germany.
Alexandra PatinDepartment of Psychiatry, University of Bonn, Bonn, Germany.
Katrin PreckelDepartment of Psychiatry, University of Bonn, Bonn, Germany.
Benjamin BeckerDepartment of Psychiatry, University of Bonn, Bonn, Germany.
Annika WalterDepartment of Psychiatry, University of Bonn, Bonn, Germany.
Katharina DomschkeDepartment of Psychiatry, Psychosomatics and Psychotherapy, University of Wuerzburg, Wuerzburg, Germany.
Valery GrinevichSchaller Research Group on Neuropeptides, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Wolfgang MaierDepartment of Psychiatry, University of Bonn, Bonn, Germany.
René HurlemannDepartment of Psychiatry, University of Bonn, Bonn, Germany.
University of Bonn · DEGerman Center for Neurodegenerative Diseases · DEHeidelberg University · DEUniversity of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In human evolution, social group living and Pavlovian fear conditioning have evolved as adaptive mechanisms promoting survival and reproductive success. The evolutionarily conserved hypothalamic peptide oxytocin is a key modulator of human sociality, but its effects on fear conditioning are still elusive. In the present randomized controlled study involving 97 healthy male subjects, we therefore employed functional magnetic resonance imaging and simultaneous skin conductance response (SCR) measures to characterize the modulatory influence of intranasal oxytocin (24 IU) on Pavlovian fear conditioning. We found that the peptide strengthened conditioning on both the behavioral and neural levels. Specifically, subjects exhibited faster task-related responses and enhanced SCRs to fear-associated stimuli in the late phase of conditioning, which was paralleled by heightened activity in cingulate cortex subregions in the absence of changes in amygdala function. This speaks against amygdalocentric views of oxytocin having pure anxiolytic-like effects. Instead, it suggests that the peptide enables extremely rapid and flexible adaptation to fear signals in social contexts, which may confer clear evolutionary advantages but could also elevate vulnerability for the pathological sequelae of interpersonal trauma.

Indexed as

Administration, IntranasalAdultBrain MappingConditioning, ClassicalDouble-Blind MethodFearGalvanic Skin ResponseGyrus CinguliHumansMagnetic Resonance ImagingMaleOxytocinYoung AdultOxytocin

Identifiers

PMID26272050
PMCPMC4748433
OpenAlexW1185634228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.